FDA Inspection 1009132 — Cosette Pharmaceuticals, Inc.

Cosette Pharmaceuticals, Inc. — FEI 2210277

The FDA completed an inspection of Cosette Pharmaceuticals, Inc. on Jan 26, 2017 in South Plainfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 26, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
South Plainfield, NJ (United States)